FilingReader Intelligence

Medplus subsidiary receives suspension order for drug license

July 9, 2025 at 01:29 PM UTCBy FilingReader AI

Medplus Health Services announced that its subsidiary, Optival Health Solutions Private Limited, received a suspension order on a drug license for a store situated in Karnataka. The order, received on August 7, 2025, was issued by the Assistant Director, Drugs Control Administration, Bangalore Circle. The drug license suspension is for three days for a store situated at Hosadurga Main Road, Karnataka. The company estimates a potential revenue loss of approximately INR0.69 lacs due to the suspension, attributed to violations under rule 65 of drugs and cosmetics act, 1940 and drugs and cosmetics rules, 1945. The company stated that the information is available on their website and the websites of the BSE and NSE.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Medplus Health Services publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →